Table 1 Clinicopathological characteristics and expression of miR-216 in studied cervical cancer patients
Factor | No. | (%) |
|---|---|---|
Age (years) | ||
  ≤ 55 | 76 | 50.6 |
  > 55 | 74 | 49.7 |
FIGO stage | ||
 I/II | 51 | 34 |
 III/IV | 99 | 66 |
Histology | ||
 Squamous | 121 | 80.7 |
 Others | 29 | 19.3 |
Survival status | ||
 Alive | 55 | 36.7 |
 Dead | 95 | 63.3 |
Expression of miR-216 | ||
 Low expression | 75 | 50 |
 High expression | 75 | 50 |